Spin-off - Cortigent, Inc.

Form Type: 10-12B

Filing Date: 2025-05-28

Corporate Action: Spin-off

Type: New

Accession Number: 000175392625000888

Filing Summary: Cortigent, Inc. is filing a registration statement for the purpose of registering securities under the Exchange Act of 1934. The filing details the registration of its common stock, valued at $0.001 per share, with the Nasdaq Stock Market. The document indicates that Cortigent is categorized as a smaller reporting company and an emerging growth company. Key sections of the information statement include details about the spin-off process, risk factors associated with the undertaking, and an overview of financial conditions and results of operations. This registration includes references to several items of business disclosure, executive compensation, and security ownership. The process related to the spin-off reflects Cortigent's strategic plans and financial maneuvers leading up to this corporate event. Additionally, the registration statement also outlines the separation and distribution agreement with Vivani Medical, Inc., reflecting corporate restructuring efforts.